Evidence map›Paper›PMID 33538335›Full record

ArticleBritish journal of haematology2021

COVID-19-induced endotheliitis: emerging evidence and possible therapeutic strategies.

Eleonora Calabretta, Jose M Moraleda, Massimo Iacobelli, Ruben Jara, Israel Vlodavsky, Peter O'Gorman, Antonio Pagliuca, Clifton Mo, Rebecca M Baron, Alessio Aghemo and 4 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in British journal of haematology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Article
  8. Review
  9. Effects of Cytokines (or Activating Factors) on Arterial Endothelial Cells.International journal of molecular sciences · 2025
    Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Review
  20. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Eleonora CalabrettaDepartment of Oncology and Hematology, Humanitas Cancer Center, Humanitas Clinical and Research Center - IRCCS, Rozzano, Milan, Italy.ORCID 0000-0002-8105-1322
Jose M MoraledaDepartment of Hematology, Stem Cell Transplant and Cell Therapy Unit, Virgen de la Arrixaca University Hospital, IMIB-Arrixaca, University of Murcia, Murcia, Spain.
Massimo IacobelliTechitra Srl, Milan, Italy.
Ruben JaraDepartment of Critical Care Medicine, Virgen de la Arrixaca University Hospital, IMIB-Arrixaca, University of Murcia, Murcia, Spain.
Israel VlodavskyThe Rappaport Faculty of Medicine, Technion Integrated Cancer Center (TICC), Haifa, Israel.
Peter O'GormanHaematology Department, Mater Misericordiae University Hospital, Dublin, Ireland.
Antonio PagliucaDepartment of Haematology, Kings College Hospital NHS Foundation Trust, London, UK.
Clifton MoDepartment of Medical Oncology, Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
Rebecca M BaronDivision of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Alessio AghemoDivision of Hepatology and Internal Medicine, Humanitas Clinical and Research Center - IRCCS, Milan, Italy.
Robert SoifferDepartment of Medical Oncology, Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
Jawed FareedLoyola University Medical Center, Chicago, IL, USA.
Carmelo Carlo-StellaDepartment of Oncology and Hematology, Humanitas Cancer Center, Humanitas Clinical and Research Center - IRCCS, Rozzano, Milan, Italy.ORCID 0000-0003-3144-0124
Paul RichardsonDepartment of Medical Oncology, Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.

Funding

AIRC #20575 to CC-S
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

PandemicsAnemia, Sickle CellAnticoagulantsApoptosisBone Marrow TransplantationCOVID-19Endothelial CellsEndothelium, VascularGlucuronidaseGraft vs Host DiseaseHeparanaseHeparinHepatic Veno-Occlusive DiseaseHumansIdiopathic Interstitial PneumoniasInterleukin-6AnticoagulantsdefibrotideGlucuronidaseHeparanaseHeparinIL6 protein, humanInterleukin-6Polydeoxyribonucleotides

Identifiers

PMID33538335
PMCPMC8014053

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.